首页 > 最新文献

Gastrointestinal disorders (Basel, Switzerland)最新文献

英文 中文
Structure and Metabolic Activity of the Gut Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Combined with Functional Dyspepsia 腹泻型肠易激综合征合并功能性消化不良患者肠道微生物群的结构和代谢活性
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-07-31 DOI: 10.3390/gidisord5030024
Aleksandra Kovaleva, E. Poluektova, R. Maslennikov, O. Zolnikova, O. Shifrin, A. Kudryavtseva, G. Krasnov, M. Fedorova, A. Karchevskaya, V. Ivashkin
Gut dysbiosis presents in many digestive diseases. The aim of this study is to investigate the composition of the gut microbiota and its metabolic activity in patients with diarrhea-predominant irritable bowel syndrome combined with functional dyspepsia (I + D). This study included 60 patients with I + D and 20 healthy controls. Gut microbiota composition was studied using 16S rRNA gene sequencing. The short-chain fatty acids (SCFAs) spectrum was determined via gas–liquid chromatography. Patients with I + D had an increase in the abundance of Holdemanella, Erysipelotrichaceae, Erysipelotrichales, Prevotellaceae, Agathobacter, Slackia, Lactococcus, Pseudomonadaceae, Stenotrophomonas, Xanthomonadaceae, Rhizobiaceae, Erysipelatoclostridiaceae, Lachnospiraceae, and other taxa in addition to a decrease in the abundance of Frisingicoccus, Ralstonia, Burkholderiaceae, Hungatella, Eisenbergiella, Parabacteroides, Peptostreptococcaceae, Merdibacter, Bilophila, Rikenellaceae, Tannerellaceae, Bacteroidaceae, and Flavonifractor in comparison to controls. Patients with I + D showed significantly higher total SCFA content in feces; increased absolute content of acetic acid, propionic acid, butyric acid, and isoacids; and a significant negative shift in the anaerobic index. The relative levels of the main SCFAs and isoacids in the patient group did not differ significantly from those in the control group. The fecal acetate and isoacid levels correlated with the severity of diarrhea. The fecal butyrate level correlated with the severity of flatulence.
肠道微生态失调出现在许多消化系统疾病中。本研究的目的是研究腹泻型肠易激综合征合并功能性消化不良(I+D)患者的肠道微生物群组成及其代谢活性。这项研究包括60名I+D患者和20名健康对照。使用16S rRNA基因测序研究肠道微生物群组成。通过气相色谱法测定了短链脂肪酸(SCFAs)的光谱。I+D患者的Holdemanella、丹毒科、丹毒目、普雷沃菌科、玛瑙菌科、松弛菌属、乳球菌属、假单胞菌科、窄养单胞菌属、黄单藻科、根霉科、丹皮菌科、Lachnospiraceae和其他分类群的丰度增加,此外,Frisingicoccus、Ralstonia、Burkholderiaceae、Hungatela的丰度减少,与对照组相比,艾森伯格菌属、拟杆菌属、Peptostreptoccaceae、Merdibacter、嗜胆菌属、Rikenellaceae、Tannerellaceae,拟杆菌科和Flavonifractor。I+D患者粪便中SCFA总含量显著升高;乙酸、丙酸、丁酸和异酸的绝对含量增加;厌氧指数显著负移。患者组的主要SCFA和异酸的相对水平与对照组没有显著差异。粪便乙酸盐和异酸水平与腹泻的严重程度相关。粪便丁酸盐水平与胀气的严重程度相关。
{"title":"Structure and Metabolic Activity of the Gut Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Combined with Functional Dyspepsia","authors":"Aleksandra Kovaleva, E. Poluektova, R. Maslennikov, O. Zolnikova, O. Shifrin, A. Kudryavtseva, G. Krasnov, M. Fedorova, A. Karchevskaya, V. Ivashkin","doi":"10.3390/gidisord5030024","DOIUrl":"https://doi.org/10.3390/gidisord5030024","url":null,"abstract":"Gut dysbiosis presents in many digestive diseases. The aim of this study is to investigate the composition of the gut microbiota and its metabolic activity in patients with diarrhea-predominant irritable bowel syndrome combined with functional dyspepsia (I + D). This study included 60 patients with I + D and 20 healthy controls. Gut microbiota composition was studied using 16S rRNA gene sequencing. The short-chain fatty acids (SCFAs) spectrum was determined via gas–liquid chromatography. Patients with I + D had an increase in the abundance of Holdemanella, Erysipelotrichaceae, Erysipelotrichales, Prevotellaceae, Agathobacter, Slackia, Lactococcus, Pseudomonadaceae, Stenotrophomonas, Xanthomonadaceae, Rhizobiaceae, Erysipelatoclostridiaceae, Lachnospiraceae, and other taxa in addition to a decrease in the abundance of Frisingicoccus, Ralstonia, Burkholderiaceae, Hungatella, Eisenbergiella, Parabacteroides, Peptostreptococcaceae, Merdibacter, Bilophila, Rikenellaceae, Tannerellaceae, Bacteroidaceae, and Flavonifractor in comparison to controls. Patients with I + D showed significantly higher total SCFA content in feces; increased absolute content of acetic acid, propionic acid, butyric acid, and isoacids; and a significant negative shift in the anaerobic index. The relative levels of the main SCFAs and isoacids in the patient group did not differ significantly from those in the control group. The fecal acetate and isoacid levels correlated with the severity of diarrhea. The fecal butyrate level correlated with the severity of flatulence.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49644199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease 炎症性肠病患者多发性硬化的患病率
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-06-30 DOI: 10.3390/gidisord5030023
N. Pérez-Diaz-Del-Campo, G. P. Caviglia, Giorgia La Piana, Marta Vernero, V. Schillaci, A. Armandi, F. Stalla, Demis Pitoni, E. Bugianesi, A. Ciancio, P. Cavalla, D. Ribaldone
Being two immune-mediated diseases (IMIDs), the association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) is plausible, but data in the literature are conflicting. The aim of our study was to evaluate the possible association between IBD and MS in a cohort of patients with IBD. In a retrospective study, we examined the medical records of 5739 patients with a confirmed diagnosis of IBD followed in our clinic between 1978 and 2022. Among these patients, we identified 14 with MS, with a prevalence of 0.24%. The reported prevalence of MS in the general population in Northern Italy in 2021 was 0.18% (p = 0.24). For each of the patients with MS identified, more than ten patients without MS were analyzed. The 14 MS cases were then compared with 342 controls. From the 14 patients with MS, 12 (85.7%) were female and 2 (14.3%) were male, while in the control group, 158 (46.2%) were female and 184 (53.8%) were male (p = 0.004). As for therapy, significant differences were found in mesalazine (5 (41.7%) cases vs. 317 (92.7%) controls, p < 0.0001) and anti-TNF treatment (0% cases vs. 26.6% controls, p = 0.03, respectively) at the time of MS diagnosis. Moreover, a Kaplan–Meier curve analysis showed that the 20-year survival probability was 98.4% for patients with IBD, while for patients diagnosed with MS and IBD it was 82.1% (p = 0.02). In conclusion, patients with IBD have a similar risk of developing MS compared to the general population, but female sex appears to increase the risk. Indeed, life expectancy at 20 years for patients with IBD and MS is lower than for patients with IBD alone.
作为两种免疫介导的疾病(IMIDs),多发性硬化症(MS)和炎症性肠病(IBD)之间的联系似乎是合理的,但文献中的数据是相互矛盾的。本研究的目的是在一组IBD患者中评估IBD与MS之间可能的关联。在一项回顾性研究中,我们检查了1978年至2022年间在我们诊所确诊为IBD的5739例患者的医疗记录。在这些患者中,我们确定了14例MS,患病率为0.24%。据报道,2021年意大利北部普通人群中多发性硬化症的患病率为0.18% (p = 0.24)。对于每一个确定的多发性硬化症患者,分析了10多个非多发性硬化症患者。将14例MS病例与342例对照进行比较。14例MS患者中,女性12例(85.7%),男性2例(14.3%),对照组女性158例(46.2%),男性184例(53.8%)(p = 0.004)。治疗方面,MS诊断时美萨拉嗪组(5例(41.7%)vs对照组317例(92.7%),p < 0.0001)和抗tnf治疗组(0% vs 26.6%, p = 0.03)差异有统计学意义。Kaplan-Meier曲线分析显示,IBD患者20年生存率为98.4%,MS合并IBD患者20年生存率为82.1% (p = 0.02)。总之,与一般人群相比,IBD患者发生MS的风险相似,但女性似乎增加了风险。的确,IBD合并MS患者的预期寿命为20岁,低于单纯IBD患者。
{"title":"Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease","authors":"N. Pérez-Diaz-Del-Campo, G. P. Caviglia, Giorgia La Piana, Marta Vernero, V. Schillaci, A. Armandi, F. Stalla, Demis Pitoni, E. Bugianesi, A. Ciancio, P. Cavalla, D. Ribaldone","doi":"10.3390/gidisord5030023","DOIUrl":"https://doi.org/10.3390/gidisord5030023","url":null,"abstract":"Being two immune-mediated diseases (IMIDs), the association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) is plausible, but data in the literature are conflicting. The aim of our study was to evaluate the possible association between IBD and MS in a cohort of patients with IBD. In a retrospective study, we examined the medical records of 5739 patients with a confirmed diagnosis of IBD followed in our clinic between 1978 and 2022. Among these patients, we identified 14 with MS, with a prevalence of 0.24%. The reported prevalence of MS in the general population in Northern Italy in 2021 was 0.18% (p = 0.24). For each of the patients with MS identified, more than ten patients without MS were analyzed. The 14 MS cases were then compared with 342 controls. From the 14 patients with MS, 12 (85.7%) were female and 2 (14.3%) were male, while in the control group, 158 (46.2%) were female and 184 (53.8%) were male (p = 0.004). As for therapy, significant differences were found in mesalazine (5 (41.7%) cases vs. 317 (92.7%) controls, p < 0.0001) and anti-TNF treatment (0% cases vs. 26.6% controls, p = 0.03, respectively) at the time of MS diagnosis. Moreover, a Kaplan–Meier curve analysis showed that the 20-year survival probability was 98.4% for patients with IBD, while for patients diagnosed with MS and IBD it was 82.1% (p = 0.02). In conclusion, patients with IBD have a similar risk of developing MS compared to the general population, but female sex appears to increase the risk. Indeed, life expectancy at 20 years for patients with IBD and MS is lower than for patients with IBD alone.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47049859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ileocolic Anastomosis Dehiscence in Colorectal Cancer Surgery 结直肠癌手术中回肠结肠吻合口破裂
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-06-12 DOI: 10.3390/gidisord5020022
Sara Lima Gomes, P. Santos, J. Costa Pereira, Sandra F. Martins
Background: Anastomotic leakage (AL) is one of the most feared complications in colorectal cancer (CRC) surgery. Although many series have reported the general risk factors for AL, published studies focusing on ileocolic anastomosis are scarce. The main aim of this study was to identify potential risk factors associated with ileocolic anastomosis dehiscence in surgery for CRC. Methods: A total of 188 patients who underwent primary ileocolic anastomosis after elective CRC surgery in Braga’s Hospital from November of 2018 to February of 2022 were included. A multivariate logistic regression analysis was carried out to identify independent risk factors for AL. Results: AL occurred in 13 patients (6.9%), and about three-fourths of these patients required surgical re-intervention. The mortality rate was 5.3%. Diabetes mellitus, ASA score of ≥3, laparotomy or conversion to laparotomy approach, postoperative blood transfusion, and postoperative hypoalbuminemia were associated with an increased risk of AL. In the multivariable analysis, postoperative hypoalbuminemia (p = 0.018; OR: 0.281; CI: 0.098; 0.806) and shorter operating time (p = 0.038; OR: 0.985; CI: 0.972; 0.999) were independent risk factors for AL. Conclusions: Postoperative hypoalbuminemia and shorter operating time are independent risk factors for AL after ileocolic anastomosis.
背景:吻合口渗漏(AL)是癌症(CRC)手术中最令人担忧的并发症之一。尽管许多系列报道了AL的一般危险因素,但已发表的关于回结肠吻合的研究很少。本研究的主要目的是确定CRC手术中与回结肠吻合口裂开相关的潜在危险因素。方法:纳入2018年11月至2022年2月在布拉加医院接受选择性CRC手术后的188名患者。对AL的独立危险因素进行了多元logistic回归分析。结果:AL发生在13例患者中(6.9%),其中约四分之三的患者需要手术再干预。死亡率为5.3%。糖尿病、ASA评分≥3、剖腹手术或转为剖腹手术、术后输血和术后低白蛋白血症与AL风险增加有关。在多变量分析中,术后低蛋白血症(p=0.018;OR:0.281;CI:0.098;0.806)和手术时间短(p=0.038;OR:0.985;CI:0.972;0.999)是AL的独立危险因素。
{"title":"Ileocolic Anastomosis Dehiscence in Colorectal Cancer Surgery","authors":"Sara Lima Gomes, P. Santos, J. Costa Pereira, Sandra F. Martins","doi":"10.3390/gidisord5020022","DOIUrl":"https://doi.org/10.3390/gidisord5020022","url":null,"abstract":"Background: Anastomotic leakage (AL) is one of the most feared complications in colorectal cancer (CRC) surgery. Although many series have reported the general risk factors for AL, published studies focusing on ileocolic anastomosis are scarce. The main aim of this study was to identify potential risk factors associated with ileocolic anastomosis dehiscence in surgery for CRC. Methods: A total of 188 patients who underwent primary ileocolic anastomosis after elective CRC surgery in Braga’s Hospital from November of 2018 to February of 2022 were included. A multivariate logistic regression analysis was carried out to identify independent risk factors for AL. Results: AL occurred in 13 patients (6.9%), and about three-fourths of these patients required surgical re-intervention. The mortality rate was 5.3%. Diabetes mellitus, ASA score of ≥3, laparotomy or conversion to laparotomy approach, postoperative blood transfusion, and postoperative hypoalbuminemia were associated with an increased risk of AL. In the multivariable analysis, postoperative hypoalbuminemia (p = 0.018; OR: 0.281; CI: 0.098; 0.806) and shorter operating time (p = 0.038; OR: 0.985; CI: 0.972; 0.999) were independent risk factors for AL. Conclusions: Postoperative hypoalbuminemia and shorter operating time are independent risk factors for AL after ileocolic anastomosis.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47103173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Functional Gastrointestinal Disorders (Rome IV Criteria) among a Cohort of New Zealand Children 新西兰儿童队列中功能性胃肠疾病的患病率(罗马IV标准
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-06-09 DOI: 10.3390/gidisord5020021
A. Vernon-Roberts, India Alexander, A. Day
Functional gastrointestinal disorders (FGIDs) are characterised by recurring gastrointestinal symptoms that are not secondary to organic disease. FGIDs may cause reduced quality of life, with approximately 22% of children experiencing at least one FGID. This study aimed to assess FGID prevalence among children attending a tertiary care hospital in New Zealand (NZ). Methods: Children aged ≥ four years were prospectively recruited from Christchurch Hospital, NZ. Data were collected on demographics, medical history, gastrointestinal symptoms (Rome IV), and quality of life (EQ-5D-Y). An analysis was carried out using analysis of variance and the chi-squared test of independence. Results: The cohort included 156 children, with a mean age of 9.5 years (SD 3.3), 56% male. According to the Rome IV criteria, 29% experienced at least one FGID, most commonly functional constipation and functional dyspepsia. FGID symptoms were associated with Māori ethnicity (p = 0.012) and parental FGID (p < 0.001). Quality of life was lower in the FGID group in the domain ‘Feeling worried, sad, or unhappy’ (p = 0.002). Conclusion: the association of FGIDs with worse quality of life, in particular relating to worry and sadness, should highlight the importance of providing support to school age children experiencing FGID symptoms.
功能性胃肠道疾病(FGID)的特点是反复出现胃肠道症状,而不是继发于器质性疾病。女性生殖器切割可能导致生活质量下降,约22%的儿童至少经历过一次女性生殖器切割。本研究旨在评估在新西兰一家三级护理医院就诊的儿童中女性生殖器切割的患病率。方法:从新西兰基督城医院前瞻性招募年龄≥4岁的儿童。收集人口统计学、病史、胃肠道症状(罗马IV)和生活质量(EQ-5D-Y)的数据。使用方差分析和独立性卡方检验进行分析。结果:该队列包括156名儿童,平均年龄9.5岁(SD 3.3),56%为男性。根据罗马IV标准,29%的患者至少经历过一次FGID,最常见的是功能性便秘和功能性消化不良。FGID症状与毛利族(p=0.012)和父母FGID(p<0.001)有关。FGID组的生活质量在“感到担忧、悲伤或不快乐”(p=0.002)方面较低。结论:FGID与较差的生活质量有关,特别是与担忧和悲伤有关,应强调为出现女性生殖器切割症状的学龄儿童提供支持的重要性。
{"title":"Prevalence of Functional Gastrointestinal Disorders (Rome IV Criteria) among a Cohort of New Zealand Children","authors":"A. Vernon-Roberts, India Alexander, A. Day","doi":"10.3390/gidisord5020021","DOIUrl":"https://doi.org/10.3390/gidisord5020021","url":null,"abstract":"Functional gastrointestinal disorders (FGIDs) are characterised by recurring gastrointestinal symptoms that are not secondary to organic disease. FGIDs may cause reduced quality of life, with approximately 22% of children experiencing at least one FGID. This study aimed to assess FGID prevalence among children attending a tertiary care hospital in New Zealand (NZ). Methods: Children aged ≥ four years were prospectively recruited from Christchurch Hospital, NZ. Data were collected on demographics, medical history, gastrointestinal symptoms (Rome IV), and quality of life (EQ-5D-Y). An analysis was carried out using analysis of variance and the chi-squared test of independence. Results: The cohort included 156 children, with a mean age of 9.5 years (SD 3.3), 56% male. According to the Rome IV criteria, 29% experienced at least one FGID, most commonly functional constipation and functional dyspepsia. FGID symptoms were associated with Māori ethnicity (p = 0.012) and parental FGID (p < 0.001). Quality of life was lower in the FGID group in the domain ‘Feeling worried, sad, or unhappy’ (p = 0.002). Conclusion: the association of FGIDs with worse quality of life, in particular relating to worry and sadness, should highlight the importance of providing support to school age children experiencing FGID symptoms.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42929140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease 脂质过多和非酒精性脂肪肝引起的肝毒性的分子机制和介质
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-05-25 DOI: 10.3390/gidisord5020020
C. Finelli
The paper reviews some of the mechanisms implicated in hepatotoxicity, which is induced by an excess of lipids. The paper spans a wide variety of topics: from the molecular mechanisms of excess lipids, to the therapy of hyperlipidemia, to the hepatotoxicity of lipid-lowering drugs. NAFLD is currently the leading cause of chronic liver disease in Western countries; the molecular mechanisms leading to NAFLD are only partially understood and there are no effective therapeutic interventions. The prevalence of liver disease is constantly increasing in industrialized countries due to a number of lifestyle variables, including excessive caloric intake, unbalanced diet, lack of physical activity, and abuse of hepatotoxic medicines. Considering the important functions of cell death and inflammation in the etiology of the majority, if not all, liver diseases, one efficient therapeutic treatment may include the administration of hepatoprotective and anti-inflammatory drugs, either alone or in combination. Clinical trials are currently being conducted in cohorts of patients with different liver diseases in order to explore this theory.
本文综述了一些涉及肝毒性的机制,这是由过量的脂质诱导的。本文涵盖了广泛的主题:从过量脂质的分子机制,到高脂血症的治疗,再到降脂药物的肝毒性。NAFLD目前是西方国家慢性肝病的主要原因;导致NAFLD的分子机制只被部分理解,也没有有效的治疗干预措施。在工业化国家,由于一些生活方式变量,包括过量的热量摄入、不平衡的饮食、缺乏身体活动和滥用肝毒性药物,肝病的患病率不断上升。考虑到细胞死亡和炎症在大多数(如果不是全部)肝脏疾病的病因学中的重要功能,一种有效的治疗方法可能包括单独或联合使用保肝和抗炎药物。临床试验目前正在不同肝病患者队列中进行,以探索这一理论。
{"title":"Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease","authors":"C. Finelli","doi":"10.3390/gidisord5020020","DOIUrl":"https://doi.org/10.3390/gidisord5020020","url":null,"abstract":"The paper reviews some of the mechanisms implicated in hepatotoxicity, which is induced by an excess of lipids. The paper spans a wide variety of topics: from the molecular mechanisms of excess lipids, to the therapy of hyperlipidemia, to the hepatotoxicity of lipid-lowering drugs. NAFLD is currently the leading cause of chronic liver disease in Western countries; the molecular mechanisms leading to NAFLD are only partially understood and there are no effective therapeutic interventions. The prevalence of liver disease is constantly increasing in industrialized countries due to a number of lifestyle variables, including excessive caloric intake, unbalanced diet, lack of physical activity, and abuse of hepatotoxic medicines. Considering the important functions of cell death and inflammation in the etiology of the majority, if not all, liver diseases, one efficient therapeutic treatment may include the administration of hepatoprotective and anti-inflammatory drugs, either alone or in combination. Clinical trials are currently being conducted in cohorts of patients with different liver diseases in order to explore this theory.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41789521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effects of the Selective Decontamination of the Digestive Tract (SDD) on Pulmonary Secondary Infections in Patients with COVID-19 Acute Respiratory Distress Syndrome: A Retrospective Single Centre Experience 选择性消化道去污(SDD)对新冠肺炎急性呼吸窘迫综合征患者肺部继发感染的影响:单中心回顾性经验
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-05-18 DOI: 10.3390/gidisord5020019
G. Berlot, Edoardo Moro, Stefano Zio, S. Zanchi, A. Randino, A. Tomasini
Definitive data on the incidence rate of ventilator-associated pneumonia (VAP) in COVID-19 are still lacking, ranging from 29 to 58%. To date, most of the existing literature refers to patients who are not subjected to VAP prevention with selective decontamination of the digestive tract (SDD). We retrospectively collected data on all COVID-19 patients admitted to our ICU during the second phase of the pandemic with the aim of assessing the occurrence of VAP and the related mortality at 30 days and comparing our findings with the available literature. Of 213 patients, only 74 were eligible for the analysis. An incidence of 6.90 VAP per 1000 days of mechanical ventilation was detected. Apart from a smoking habit (0% vs. 10%, p < 0.005) and diabetes (14% vs. 54%, p = 0.026), patients who developed VAP did not differ significantly from those who did not regarding comorbidities, steroid use, and the severity of COVID-19. VAP were predominantly caused by mono-microbial Gram-negative or fungal infections. Mortality was significantly higher in those who developed VAP (86 vs. 33%, p = 0.002). Our evidence aligned with the available literature in assuming a possible role of SDD in reducing the incidence of VAP in COVID-19 patients, with a possible impact on related mortality and costs.
关于新冠肺炎中呼吸机相关性肺炎(VAP)发病率的确切数据仍然缺乏,从29%到58%不等。迄今为止,大多数现有文献都提到了未通过选择性消化道去污(SDD)预防VAP的患者。我们回顾性收集了在大流行第二阶段入住ICU的所有新冠肺炎患者的数据,目的是评估VAP的发生率和30天时的相关死亡率,并将我们的研究结果与现有文献进行比较。在213名患者中,只有74名符合分析条件。每1000天机械通气的VAP发生率为6.90。除了吸烟习惯(0%对10%,p<0.005)和糖尿病(14%对54%,p=0.026)外,患VAP的患者与未患VAP患者在合并症、类固醇使用和新冠肺炎严重程度方面没有显著差异。VAP主要由单微生物革兰氏阴性或真菌感染引起。VAP患者的死亡率显著较高(86%对33%,p=0.002)。我们的证据与现有文献一致,认为SDD可能在降低新冠肺炎患者VAP发病率方面发挥作用,并可能对相关死亡率和成本产生影响。
{"title":"Effects of the Selective Decontamination of the Digestive Tract (SDD) on Pulmonary Secondary Infections in Patients with COVID-19 Acute Respiratory Distress Syndrome: A Retrospective Single Centre Experience","authors":"G. Berlot, Edoardo Moro, Stefano Zio, S. Zanchi, A. Randino, A. Tomasini","doi":"10.3390/gidisord5020019","DOIUrl":"https://doi.org/10.3390/gidisord5020019","url":null,"abstract":"Definitive data on the incidence rate of ventilator-associated pneumonia (VAP) in COVID-19 are still lacking, ranging from 29 to 58%. To date, most of the existing literature refers to patients who are not subjected to VAP prevention with selective decontamination of the digestive tract (SDD). We retrospectively collected data on all COVID-19 patients admitted to our ICU during the second phase of the pandemic with the aim of assessing the occurrence of VAP and the related mortality at 30 days and comparing our findings with the available literature. Of 213 patients, only 74 were eligible for the analysis. An incidence of 6.90 VAP per 1000 days of mechanical ventilation was detected. Apart from a smoking habit (0% vs. 10%, p < 0.005) and diabetes (14% vs. 54%, p = 0.026), patients who developed VAP did not differ significantly from those who did not regarding comorbidities, steroid use, and the severity of COVID-19. VAP were predominantly caused by mono-microbial Gram-negative or fungal infections. Mortality was significantly higher in those who developed VAP (86 vs. 33%, p = 0.002). Our evidence aligned with the available literature in assuming a possible role of SDD in reducing the incidence of VAP in COVID-19 patients, with a possible impact on related mortality and costs.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46529470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the Inheritance of Microbiome-Deficiency: Paediatric Functional Gastrointestinal Disorders, the Immune System and the Gut–Brain Axis 微生物群缺乏的遗传:儿科功能性胃肠疾病、免疫系统和肠脑轴
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-05-15 DOI: 10.3390/gidisord5020018
David Smith, S. Jheeta, G. López-Cortés, B. Street, Hannya V. Fuentes, Miryam Palacios-Pérez
Like the majority of non-communicable diseases that have recently gained attention, functional gastrointestinal (GI) disorders (FGID) in both children and adults are caused by a variety of medical conditions. In general, while it is often thought that common conditions such as obesity may cause other problems, for example, asthma or mental health issues, more consideration needs to be given to the possibility that they could both be brought on by a single underlying problem. Based on the variations in non-communicable disease, in recent years, our group has been revisiting the exact role of the intestinal microbiome within the Vertebrata. While the metabolic products of the microbiome have a role to play in the adult, our tentative conclusion is that the fully functioning, mutualistic microbiome has a primary role: to transfer antigen information from the mother to the neonate in order to calibrate its immune system, allowing it to survive within the microbial environment into which it will emerge. Granted that the microbiome possesses such a function, logic suggests the need for a robust, flexible, mechanism allowing for the partition of nutrition in the mature animal, thus ensuring the continued existence of both the vertebrate host and microbial guest, even under potentially unfavourable conditions. It is feasible that this partition process acts by altering the rate of peristalsis following communication through the gut–brain axis. The final step of this animal–microbiota symbiosis would then be when key microbes are transferred from the female to her progeny, either live offspring or eggs. According to this scheme, each animal inherits twice, once from its parents’ genetic material and once from the mother’s microbiome with the aid of the father’s seminal microbiome, which helps determine the expression of the parental genes. The key point is that the failure of this latter inheritance in humans leads to the distinctive manifestations of functional FGID disorders including inflammation and gut motility disturbances. Furthermore, it seems likely that the critical microbiome–gut association occurs in the first few hours of independent life, in a process that we term handshaking. Note that even if obvious disease in childhood is avoided, the underlying disorders may intrude later in youth or adulthood with immune system disruption coexisting with gut–brain axis issues such as excessive weight gain and poor mental health. In principle, investigating and perhaps supplementing the maternal microbiota provide clinicians with an unprecedented opportunity to intervene in long-term disease processes, even before the child is born.
与最近引起关注的大多数非传染性疾病一样,儿童和成人的功能性胃肠道疾病(FGID)是由各种医疗条件引起的。一般来说,虽然人们通常认为肥胖等常见情况可能会导致其他问题,例如哮喘或精神健康问题,但需要更多地考虑到它们可能都是由一个潜在问题引起的可能性。基于非传染性疾病的变化,近年来,我们的团队一直在重新审视肠道微生物组在脊椎动物中的确切作用。虽然微生物组的代谢产物在成人中发挥作用,但我们的初步结论是,功能齐全的互惠微生物组具有主要作用:将抗原信息从母亲传递给新生儿,以校准其免疫系统,使其能够在微生物环境中生存。假设微生物组具有这样的功能,逻辑表明需要一种强大的、灵活的机制来允许成熟动物的营养分配,从而确保脊椎动物宿主和微生物客人的持续存在,即使在潜在的不利条件下。这是可行的,这种分割过程通过改变肠-脑轴通信后的蠕动速率而起作用。这种动物-微生物群共生的最后一步将是关键微生物从雌性转移到她的后代,要么是活的后代,要么是卵。根据这一方案,每只动物遗传两次,一次来自父母的遗传物质,一次来自母亲的微生物群,借助父亲的精液微生物群,这有助于确定亲本基因的表达。关键的一点是,后一种遗传在人类中的失败导致功能性FGID障碍的独特表现,包括炎症和肠道运动障碍。此外,关键的微生物群-肠道关联似乎可能发生在独立生命的最初几个小时,在我们称之为握手的过程中。请注意,即使在儿童期避免了明显的疾病,潜在的疾病也可能在青年或成年后期侵入,免疫系统破坏与肠-脑轴问题共存,如体重过度增加和精神健康状况不佳。原则上,调查和补充母体微生物群为临床医生提供了一个前所未有的机会,可以在孩子出生前干预长期疾病过程。
{"title":"On the Inheritance of Microbiome-Deficiency: Paediatric Functional Gastrointestinal Disorders, the Immune System and the Gut–Brain Axis","authors":"David Smith, S. Jheeta, G. López-Cortés, B. Street, Hannya V. Fuentes, Miryam Palacios-Pérez","doi":"10.3390/gidisord5020018","DOIUrl":"https://doi.org/10.3390/gidisord5020018","url":null,"abstract":"Like the majority of non-communicable diseases that have recently gained attention, functional gastrointestinal (GI) disorders (FGID) in both children and adults are caused by a variety of medical conditions. In general, while it is often thought that common conditions such as obesity may cause other problems, for example, asthma or mental health issues, more consideration needs to be given to the possibility that they could both be brought on by a single underlying problem. Based on the variations in non-communicable disease, in recent years, our group has been revisiting the exact role of the intestinal microbiome within the Vertebrata. While the metabolic products of the microbiome have a role to play in the adult, our tentative conclusion is that the fully functioning, mutualistic microbiome has a primary role: to transfer antigen information from the mother to the neonate in order to calibrate its immune system, allowing it to survive within the microbial environment into which it will emerge. Granted that the microbiome possesses such a function, logic suggests the need for a robust, flexible, mechanism allowing for the partition of nutrition in the mature animal, thus ensuring the continued existence of both the vertebrate host and microbial guest, even under potentially unfavourable conditions. It is feasible that this partition process acts by altering the rate of peristalsis following communication through the gut–brain axis. The final step of this animal–microbiota symbiosis would then be when key microbes are transferred from the female to her progeny, either live offspring or eggs. According to this scheme, each animal inherits twice, once from its parents’ genetic material and once from the mother’s microbiome with the aid of the father’s seminal microbiome, which helps determine the expression of the parental genes. The key point is that the failure of this latter inheritance in humans leads to the distinctive manifestations of functional FGID disorders including inflammation and gut motility disturbances. Furthermore, it seems likely that the critical microbiome–gut association occurs in the first few hours of independent life, in a process that we term handshaking. Note that even if obvious disease in childhood is avoided, the underlying disorders may intrude later in youth or adulthood with immune system disruption coexisting with gut–brain axis issues such as excessive weight gain and poor mental health. In principle, investigating and perhaps supplementing the maternal microbiota provide clinicians with an unprecedented opportunity to intervene in long-term disease processes, even before the child is born.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43437003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary Tract Infections in Patients Hospitalized in a Gastroenterology Department—Study from a Tertiary Regional Hospital in South-East Poland 消化内科住院患者的尿路感染——来自波兰东南部一家三级地区医院的研究
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-05-06 DOI: 10.3390/gidisord5020017
J. Gruszecka, R. Filip
A retrospective analysis of urine culture results was conducted for adult patients treated between 1 January 2017 and 31 December 2021 at the Department of Gastroenterology in Rzeszow (southern Poland). A total of 102 patients were sampled for microbiological tests during the analyzed period, with microbial growth found in 30 samples. The purpose of our study was to determine the predominant bacterial species present in the urine of patients hospitalized in the Department of Gastroenterology, as well as their drug susceptibility. The data obtained from medical records included, for example, urine culture results and the antibiotic susceptibility of the isolated microorganisms. The material for the study was collected according to the current procedures. During the analyzed period, urine was collected from a total of 102 patients, and 30 positive samples were found. The predominant pathogen was Escherichia coli (n = 10 (33.33% of all positive results), p < 0.001); the second most common microorganism was Enterococcus faecalis (n = 5 (16.67% of all positive results), p < 0.001). In vitro susceptibility testing showed E. coli, ESBL (ESBL strain with extended-spectrum beta-lactamase) (n = 2 (6.67% of all positive results), p = 0.055) and Klebsiella pneumoniae, ESBL (n = 3 (10% of all positive results), p = 0.005). Urinary tract infection (UTI) was an extremely common problem.
对2017年1月1日至2021年12月31日在Rzeszow(波兰南部)消化内科治疗的成年患者的尿液培养结果进行了回顾性分析。在分析期间,共对102名患者进行了微生物学检测,在30份样本中发现了微生物生长。我们研究的目的是确定在消化内科住院患者尿液中存在的主要细菌种类,以及他们的药物敏感性。从医疗记录中获得的数据包括,例如,尿液培养结果和分离的微生物对抗生素的敏感性。本研究的材料是按照现行程序收集的。在分析期间,共收集102例患者尿液,发现30例阳性样本。优势病原菌为大肠杆菌(n = 10,占所有阳性结果的33.33%,p < 0.001);第二常见的微生物为粪肠球菌(n = 5,占所有阳性结果的16.67%,p < 0.001)。体外药敏试验结果显示,大肠杆菌ESBL(具有广谱β -内酰胺酶的ESBL菌株)(n = 2(占所有阳性结果的6.67%),p = 0.055)和肺炎克雷伯菌ESBL (n = 3(占所有阳性结果的10%),p = 0.005)。尿路感染(UTI)是一个非常常见的问题。
{"title":"Urinary Tract Infections in Patients Hospitalized in a Gastroenterology Department—Study from a Tertiary Regional Hospital in South-East Poland","authors":"J. Gruszecka, R. Filip","doi":"10.3390/gidisord5020017","DOIUrl":"https://doi.org/10.3390/gidisord5020017","url":null,"abstract":"A retrospective analysis of urine culture results was conducted for adult patients treated between 1 January 2017 and 31 December 2021 at the Department of Gastroenterology in Rzeszow (southern Poland). A total of 102 patients were sampled for microbiological tests during the analyzed period, with microbial growth found in 30 samples. The purpose of our study was to determine the predominant bacterial species present in the urine of patients hospitalized in the Department of Gastroenterology, as well as their drug susceptibility. The data obtained from medical records included, for example, urine culture results and the antibiotic susceptibility of the isolated microorganisms. The material for the study was collected according to the current procedures. During the analyzed period, urine was collected from a total of 102 patients, and 30 positive samples were found. The predominant pathogen was Escherichia coli (n = 10 (33.33% of all positive results), p < 0.001); the second most common microorganism was Enterococcus faecalis (n = 5 (16.67% of all positive results), p < 0.001). In vitro susceptibility testing showed E. coli, ESBL (ESBL strain with extended-spectrum beta-lactamase) (n = 2 (6.67% of all positive results), p = 0.055) and Klebsiella pneumoniae, ESBL (n = 3 (10% of all positive results), p = 0.005). Urinary tract infection (UTI) was an extremely common problem.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47919423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Italian Cross-Cultural Adaptation of a Knowledge Assessment Tool (IBD-KID2) for Children with Inflammatory Bowel Disease 炎症性肠病儿童知识评估工具(IBD-KID2)的意大利跨文化适应
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-04-20 DOI: 10.3390/gidisord5020016
A. Vernon-Roberts, F. Musto, M. Aloi, A. Day
Background: For children with inflammatory bowel disease (IBD), understanding their condition may lead to better outcomes. Knowledge assessment is imperative to identify where education may be required. An IBD knowledge assessment tool (IBD-KID2) is available in English; the aim of this study was to translate IBD-KID2 in to Italian and assess its validity/reliability among children with IBD. Methods: IBD-KID2 has fifteen items, scoring one point per correct answer. IBD-KID2 items were assessed for cultural comprehension/relevance by Italian gastroenterologists using a content validity index; those items with a maximum score proportion <0.78 were reviewed. IBD-KID2 was then translated using ‘forward–backward’ process and reviewed for content/meaning. A prospective study among Italian children with IBD enabled score comparisons with established populations (z test), and reliability was assessed using test–retest completion (Pearson correlation (r), paired t-test). Results: Twenty-five children participated: 16 (64%) male, mean age 14.9 years (SD2.4), Crohn’s disease 13 (52%). The mean IBD-KID2 score was 8.8 (SD2.8), with no association with independent variables. Test–retest showed strong correlation between scores (r = 0.78, p < 0.001), with no mean difference (p = 0.39). Comparison with other pediatric IBD populations (NZ/Australia/Canada) showed no score difference (p = 0.62, CI −0.9 to 1.5). Conclusions: The translation of IBD-KID2 to Italian used a rigorous methodology. Scores showed the translated tool has equivalence and generalizability to Italian children with IBD.
背景:对于患有炎症性肠病(IBD)的儿童来说,了解他们的病情可能会带来更好的结果。知识评估对于确定哪里可能需要教育至关重要。IBD知识评估工具(IBD-KID2)有英文版本;本研究的目的是将IBD-KID2翻译成意大利语,并评估其在IBD儿童中的有效性/可靠性。方法:IBD-KID2共15项,每答对得1分。意大利胃肠病学家使用内容有效性指数评估IBD-KID2项目的文化理解/相关性;对最大得分比例<0.78的项目进行了审查。IBD-KID2随后使用“向前-向后”过程进行翻译,并对内容/含义进行审查。一项针对意大利IBD儿童的前瞻性研究使得分能够与既定人群进行比较(z检验),并使用测试-再测试完成度(Pearson相关性(r),配对t检验)评估可靠性。结果:25名儿童参与:16名(64%)男性,平均年龄14.9岁(SD2.4),克罗恩病13名(52%)。IBD-KID2的平均得分为8.8(SD2.8),与自变量无关。测试-重新测试显示分数之间有很强的相关性(r=0.78,p<0.001),没有平均差异(p=0.39)。与其他儿科IBD人群(新西兰/澳大利亚/加拿大)的比较显示没有分数差异(p=0.62,CI−0.9至1.5)。结论:IBD-KID2翻译成意大利语使用了严格的方法。评分显示,翻译后的工具对患有IBD的意大利儿童具有等效性和可推广性。
{"title":"Italian Cross-Cultural Adaptation of a Knowledge Assessment Tool (IBD-KID2) for Children with Inflammatory Bowel Disease","authors":"A. Vernon-Roberts, F. Musto, M. Aloi, A. Day","doi":"10.3390/gidisord5020016","DOIUrl":"https://doi.org/10.3390/gidisord5020016","url":null,"abstract":"Background: For children with inflammatory bowel disease (IBD), understanding their condition may lead to better outcomes. Knowledge assessment is imperative to identify where education may be required. An IBD knowledge assessment tool (IBD-KID2) is available in English; the aim of this study was to translate IBD-KID2 in to Italian and assess its validity/reliability among children with IBD. Methods: IBD-KID2 has fifteen items, scoring one point per correct answer. IBD-KID2 items were assessed for cultural comprehension/relevance by Italian gastroenterologists using a content validity index; those items with a maximum score proportion <0.78 were reviewed. IBD-KID2 was then translated using ‘forward–backward’ process and reviewed for content/meaning. A prospective study among Italian children with IBD enabled score comparisons with established populations (z test), and reliability was assessed using test–retest completion (Pearson correlation (r), paired t-test). Results: Twenty-five children participated: 16 (64%) male, mean age 14.9 years (SD2.4), Crohn’s disease 13 (52%). The mean IBD-KID2 score was 8.8 (SD2.8), with no association with independent variables. Test–retest showed strong correlation between scores (r = 0.78, p < 0.001), with no mean difference (p = 0.39). Comparison with other pediatric IBD populations (NZ/Australia/Canada) showed no score difference (p = 0.62, CI −0.9 to 1.5). Conclusions: The translation of IBD-KID2 to Italian used a rigorous methodology. Scores showed the translated tool has equivalence and generalizability to Italian children with IBD.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48531556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of TGF-β, Activin and Follistatin in Inflammatory Bowel Disease TGF-β、激活素和卵泡抑素在炎症性肠病中的作用
Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-04-11 DOI: 10.3390/gidisord5020015
Nasim Hatamzade Esfahani, A. Day
Inflammatory bowel disease (IBD) is an immune-mediated inflammatory condition predominantly affecting the gastrointestinal (GI) tract. An increasing prevalence of IBD has been observed globally. The pathogenesis of IBD includes a complex interplay between the intestinal microbiome, diet, genetic factors and immune responses. The consequent imbalance of inflammatory mediators ultimately leads to intestinal mucosal damage and defective repair. Growth factors, given their specific roles in maintaining the homeostasis and integrity of the intestinal epithelium, are of particular interest in the setting of IBD. Furthermore, direct targeting of growth factor signalling pathways involved in the regeneration of the damaged epithelium and the regulation of inflammation could be considered as therapeutic options for individuals with IBD. Several members of the transforming growth factor (TGF)-β superfamily, particularly TGF-β, activin and follistatin, are key candidates as they exhibit various roles in inflammatory processes and contribute to maintenance and homeostasis in the GI tract. This article aimed firstly to review the events involved in the pathogenesis of IBD with particular emphasis on TGF-β, activin and follistatin and secondly to outline the potential role of therapeutic manipulation of these pathways.
炎症性肠病(IBD)是一种主要影响胃肠道的免疫介导的炎症性疾病。IBD的患病率在全球范围内呈上升趋势。IBD的发病机制包括肠道微生物组、饮食、遗传因素和免疫反应之间的复杂相互作用。随之而来的炎症介质失衡最终导致肠粘膜损伤和修复缺陷。鉴于生长因子在维持肠上皮稳态和完整性方面的特殊作用,它们对IBD的发生特别感兴趣。此外,直接靶向参与受损上皮再生和炎症调节的生长因子信号通路可以被视为IBD患者的治疗选择。转化生长因子(TGF)-β超家族的几个成员,特别是TGF-β、激活素和卵泡抑素,是关键的候选者,因为它们在炎症过程中表现出各种作用,并有助于胃肠道的维持和稳态。本文旨在首先综述IBD发病机制中涉及的事件,特别是TGF-β、激活素和卵泡抑素,其次概述这些途径的潜在治疗作用。
{"title":"The Role of TGF-β, Activin and Follistatin in Inflammatory Bowel Disease","authors":"Nasim Hatamzade Esfahani, A. Day","doi":"10.3390/gidisord5020015","DOIUrl":"https://doi.org/10.3390/gidisord5020015","url":null,"abstract":"Inflammatory bowel disease (IBD) is an immune-mediated inflammatory condition predominantly affecting the gastrointestinal (GI) tract. An increasing prevalence of IBD has been observed globally. The pathogenesis of IBD includes a complex interplay between the intestinal microbiome, diet, genetic factors and immune responses. The consequent imbalance of inflammatory mediators ultimately leads to intestinal mucosal damage and defective repair. Growth factors, given their specific roles in maintaining the homeostasis and integrity of the intestinal epithelium, are of particular interest in the setting of IBD. Furthermore, direct targeting of growth factor signalling pathways involved in the regeneration of the damaged epithelium and the regulation of inflammation could be considered as therapeutic options for individuals with IBD. Several members of the transforming growth factor (TGF)-β superfamily, particularly TGF-β, activin and follistatin, are key candidates as they exhibit various roles in inflammatory processes and contribute to maintenance and homeostasis in the GI tract. This article aimed firstly to review the events involved in the pathogenesis of IBD with particular emphasis on TGF-β, activin and follistatin and secondly to outline the potential role of therapeutic manipulation of these pathways.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46797631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Gastrointestinal disorders (Basel, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1